Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Lubrizol announces the acquisition of Bavaria Medizin Technologie GmbH, a designer and manufacturer of both intravascular and nonvascular devices, by its German subsidiary Lubrizol Deutschland GmbH.
read more
Rising Pharmaceuticals announced the U.S. launch & commercial shipment of a generic version of Lyrica®, (pregabalin) Capsules, in all eight commercially available strengths.
read more
Marken announced they have acquired HRTL based in Italy along with two additional companies in Austria and Hungary under the respective names of HETO and Der Kurier.
read more
Pall Corporation has been chosen by Servier as an exclusive technology and services provider for their Gidy, France biomanufacturing facility.
read more
Dr. Reddy’s Laboratories has announced the launch of Ramelteon Tablets, 8 mg, a therapeutically equivalent generic version of Rozerem® (ramelteon, 8 mg) Tablets.
read more
Uman Diagnostics and Bio-Techne announced a strategic License and Supply Agreement for the antibodies used in the quantification of Nf-L on the ProteinSimple™-branded Ella™ immunoassay platform.
read more
OnKure entered into an exclusive license and option agreement with KDAc Therapeutics to support the continued development of KDAc’s selective histone deacetylase 3 (HDAC3) inhibitor program.
read more
Arkivum has achieved pharma-level compliance with the award of ISO 9001:2015 certification, demonstrated alignment with data-related GxP regulations.
read more
STA Pharmaceutical announced its ASU in Shanghai and API process R&D and manufacturing facility in Changzhou, have successfully passed two inspections from the FDA.
read more
Lonza announced the start of expansion to its bioconjugation facility in Visp, Switzerland together with the successful commercial approval of a third ADC produced at the site.
read more
ICON announced the appointment of Julie O’Neill as a non-executive director.
read more
Jubilant Cadista Pharmaceuticals is voluntarily recalling one lot of Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/ 0.02mg, 28x3 Blister Pack/Carton to the consumer level.
read more
Samsung Bioepis announced the FDA has approved HADLIMA™ (adalimumab-bwwd), a biosimilar referencing HUMIRA® (adalimumab).
read more
Ligand Pharmaceuticals has announced the signing of an agreement with Ab Initio Biotherapeutics whereby Ligand will acquire Ab Initio for $12 million in cash.
read more
Parexel announced the expansion of its capabilities through a new Hong Kong presence established by its healthcare consulting Health Advances subsidiary.
read more